Z-0676-2019 Class II Terminated

Recalled by Tosoh Bioscience Inc — Grove City, OH

FDA device recall Z-0676-2019 was initiated by Tosoh Bioscience Inc on Nov 30, 2018 and is designated Class II. The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 1085 units.

Recall details

Product Type
Devices
Report Date
Jan 2, 2019
Initiation Date
Nov 30, 2018
Termination Date
Jan 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1085 units

Product description

ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Adrenocorticotropic hormone (ACTH) in human EDT A plasma. Measurements of ACTH are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency and the ectopic ACTH syndrome.

Distribution pattern

US Nationwide

Code information

all lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0676-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0676-2019. Report a data issue: hello@regdatalab.com.